language_icon
EN
HI

Beryl Drugs Share price

BERLDRG

19.01

0.80 (-4.04%)
Last updated on 25 May, 2026 | 12:11 IST
Today's High

20.80

Today's Low

19.01

52 Week Low

15.92

52 Week High

30.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Beryl Drugs Chart

Beryl Drugs Share Key Metrics

Volume
310.00
Market Cap
10.05 CR
LTQ@LTP
71@19.01
ATP
20.27
Var Margin
32.03 %
Circuit Range
18.82-20.8
Delivery %
86.17 %
Value
6283.70
ASM/GSM
No
Market Lot
1

Summary

Beryl Drugs share price is ₹19.01 as of 25 May, 2026. The stock Beryl Drugs intraday movement has stayed between ₹19.01 and ₹20.80, while on a 52-week basis,Beryl Drugs price 52 week high is ₹30.00 & its 52 week low is ₹15.92.
In terms of trading activity, Beryl Drugs has recorded a volume of 310 shares, The Beryl Drugs has a market cap of ₹5071700 CR. The stock’s Average Traded Price (ATP) stands at ₹20.27, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 71 @ ₹19.01.
Beryl Drugs operates within a circuit range of ₹18.82 – ₹20.80, with a Value of ₹6283.70. The Delivery Percentage for the day is 86.17%. Additionally, Beryl Drugs currently falls under the No framework, and trades with a market lot size of 1.

Beryl Drugs Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

70.19

Sector P/B

3.44

Sec. Div. Yield

0.55

Beryl Drugs Resistance and Support

Pivot 20.04

Resistance

First Resistance

20.66

Second Resistance

21.52

Third Resistance

22.14

Support

First Support

19.18

Second Support

18.56

Third Support

17.7

Beryl Drugs Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

27.48%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

72.52%

Others

0%

Total Promoters
MAR '26
27.48%

Beryl Drugs Corporate Actions

DateAgenda
2026-05-28Audited Results
2026-04-01Notice of EGM & Others
2026-02-09Quarterly Results
2026-01-03Others
2025-11-13Quarterly Results
2025-09-02A.G.M.
2025-08-07Quarterly Results
2025-05-30Audited Results
2025-02-08Quarterly Results

Beryl Drugs News

Beryl Drugs Ltd - 524606 - Board Meeting Intimation for Consider And Approve The Audited Financial Statement Including Balance Sheet, As At 31St March, 2026, Statement Of Profit And Loss, Cash Flow And Notes Thereon For The Year Ended 31St March, 2026.

Beryl Drugs' Board of Directors will convene on May 28, 2026, to consider and approve the audited financial statements for the year ended March 31, 2026. The agenda also includes the consideration and approval of related party transactions.
May 20 2026 21:06:19

Beryl Drugs Ltd - 524606 - PROCEEDINGS OF EGM

Beryl Drugs held an Extra-Ordinary General Meeting on May 11, 2026. Shareholders approved the regularization of Mr. Shailendra Pathak as Whole Time Director and the appointment of Mrs. Neha Sarda as a Non-executive Independent Director. A material related party transaction with M/S. Aminova Infusions P. Ltd. was also approved.
May 13 2026 17:45:50

Beryl Drugs Ltd - 524606 - ANNOUNCEMENT UBDER REGULATION 44 VOTING RESULTS OF EGM HELD ON 11TH MAY 2026

Beryl Drugs Limited shareholders, at the Extra-Ordinary General Meeting on May 11, 2026, unanimously approved three key resolutions. These include the regularization of a Whole Time Director, the appointment of a Non-Executive Independent Director, and a material related party transaction.
May 12 2026 17:21:55

Beryl Drugs Ltd - 524606 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Beryl Drugs held an Extra-Ordinary General Meeting on May 11, 2026, where shareholders unanimously approved all three proposed resolutions, including two director appointments and a material related party transaction.
May 12 2026 17:19:00

Beryl Drugs Ltd - 524606 - ANNOUNCEMENT UNDER REGULATION 30

Beryl Drugs' shareholders have approved a material related-party transaction (RPT) valued at Rs.5 crore with Aminova Infusions Pvt. Ltd. This 2-year agreement enables Aminova to distribute Beryl Drugs' products in new markets like Maharashtra and Gujarat, aiming to boost turnover and profits.
May 11 2026 17:05:43

Beryl Drugs Ltd - 524606 - Shareholder Meeting / Postal Ballot-Outcome of EGM

Beryl Drugs' Extra-Ordinary General Meeting (EGM) on May 11, 2026, approved the appointment of Mr. Shailendra Pathak as a whole-time director and Mrs. Neha Sarda as an independent director. Shareholders also approved material related party transactions with M/s. Aminova Infusions Pvt. Ltd.
May 11 2026 11:43:38
Read More

Beryl Drugs Management

NamePosition
Sanjay SethiManaging Director
Sudhir SethiChairman
View More

Beryl Drugs FAQs

The Buying Price of Beryl Drugs share is 19.01 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Beryl Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.

To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 70.19 & 3.44 with sector averages, along with growth rates and financial metrics.

The Market Cap of Beryl Drugs is 10.05 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Beryl Drugs share price is 30.00 & 15.92. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Beryl Drugs belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost